Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause.
Please register your interest here if you would like updates on the meeting or topic
CANCELLED - 3rd Annual Non-Viral RNA Delivery Systems Summit
The 3rd Non-Viral RNA Delivery Systems Summit returns as the only industry dedicated event uniting RNA therapy and delivery companies to deep dive into the technical details and scientific concepts for the discovery, development and formulation of novel non-viral delivery cargoes to enable specific extrahepatic delivery of RNA therapeutics, vaccines and gene editors.
23+ industry experts will navigate through presentations and interactive discussions to provide you with the specialized roadmap towards targeted delivery with insights to:
Connect with us - join the LinkedIn community
Supercharge development of innovative and novel non-viral delivery platforms beyond lipid nanoparticles to stay ahead of the curve and achieve targeted extra-hepatic delivery with Capricor Therapeutics, Vesigen Therapeutics & Replicate Biosciences
Achieve reduced toxicity and redosability of lipid nanoparticles through understanding novel compositions and immunogenic effects for safer RNA therapeutics with Corti Therapeutics & Tessera Therapeutics
Prevent rate-limiting endosomal escape through utilizing enhancer compounds for more potent and efficacious treatments with Sapreme Technologies & University of Connecticut
Optimize delivery platforms for large RNA payloads for successful delivery of gene therapies and vaccines to widen the landscape of treatable diseases with AstraZeneca, Sanofi & Yoltech Therapeutics
Accomplish successful translation of non-viral delivery platforms by addressing key challenges in the pre-clinical to clinical roadmap for accelerating therapeutics towards approval with Northeastern University, Beam Therapeutics & Takeda Pharmaceuticals
